REQUEST A DEMO
Total
USD $0.00
Search more companies

Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. is an enterprise located in Turkiye, with the main office in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 10, 2005. Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. currently employs 42 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 25.53% in 2021. Its’ total assets recorded a growth of 25.68%.

Headquarters
No:8-1 Zafer Mahallesi 143. Sokak Esenyurt
Istanbul; Marmara; Postal Code: 34513

Contact Details: Purchase the Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. report to view the information.

Website: http://www.avrasyaecza.com

Basic Information
Total Employees:
Purchase the Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. report to view the information.
Incorporation Date:
October 10, 2005
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Avrasya Ilac Ecza Deposu Medikal Urunler Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
25.53%
Total operating revenue
25.53%
Operating profit (EBIT)
9.64%
Net Profit (Loss) for the Period
N/A
Total assets
25.68%
Total equity
-11.22%
Operating Profit Margin (ROS)
-1.54%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
39.5%
Quick Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?